Bills: AB404, AB428

Keywords: brew pub, alcoholic beverages, liquor store, licensure, regulation, Department of Taxation, fertility preservation, breast cancer, ovarian cancer, oncology, reproductive medicine, infertility, cancer treatment, egg freezing, embryo freezing, oocyte cryopreservation, sperm banking, assisted reproductive technology, health insurance mandate, Medicaid

Bills: HF4609, HF4401

Keywords: infertility, fertility treatment, fertility preservation, IVF, assisted reproductive technology, ART, oocyte retrieval, embryo transfer, egg freezing, sperm freezing, reproductive health, maternity coverage, health insurance mandate, health plan benefits, Medical Assistance, Medicaid, MinnesotaCare, family planning, oncology fertility preservation, chemotherapy

Transcript Highlights:

• pharmacy benefit and the drugs we'll pay for and the medical benefit, an outpatient clinic like oncology

Bills: HB591, HB765, HB826, HB870, HB938, HB1151, HB1162, HB1176, HB1196, HB1236, HB1241

Keywords: family leave, insurance, paid leave, employment benefits, caregiver support, liability insurance, coverage defenses, direct action, judgment enforcement, legal procedures, insurance referrals, compensation, non-licensed agents, consumer protection, insurance products, HB 870, Act 907, Louisiana insurance, health insurance, prescription drugs

Bills: HB3552, HB2984, HB4124, HB3934, HB3448, HB3131, HB4200, HB4201, HB3011, HB1912, HB3380, HB3881, HB3538, HB3851, HB3907, HB4430, HB4431, HB4457

Keywords: childcare, differential pricing, Department of Human Services, child care subsidy, licensed providers, emergency legislation, child care, subsidy program, annual report, program integrity, overpayments, ivermectin, over-the-counter medication, pharmacy immunity, healthcare access, FDA approval, prescription, public health, dentistry, licensing

Transcript Highlights:

• by funding the core program, the clinical oncology rural experience.
• investment in the rural oncology investment in the rural oncology workforce<01:09:32.960> development
• core program, the clinical oncology core program, the clinical oncology rural<01:09:37.839> experience
• , medical oncology fellows, residents, medical oncology fellows, residents, medical<01:09:48.480>
• students directly in rural oncology students directly in rural oncology practices,<01:09:53.600>

Keywords: 1187, senate, all

Transcript Highlights:

• WE DON'T COME BACK TO SESSION UNTIL JANUARY AND PART OF MY REASONING IS WE RECEIVED A LETTER FROM ONCOLOGY
• WE CAN'T HAVE A GAP FOR PEOPLE TO GET ONCOLOGY DRUGS, THEY WILL BE DEAD.
• PEOPLE GET THE DRUGS THEY WANT AND WHAT GIVES ME THE HEARTBURN IS THE LETTER FROM THE COMMUNITY ONCOLOGY
• IF ONCOLOGY PHARMACIES OR SUPPLIERS CANNOT RELIABLY OBTAIN MEDICATIONS AT OR BELOW THE STATE SET PRICE
• ON MY CONSCIENCE KNOWING WE HAVE BEEN FOREWARNED BY NATIONAL GROUPS WE MAY BE LIMITING DRUGS FOR ONCOLOGY

Transcript Highlights:

• This is funded through an NCI Community Oncology Research Program, and Dr.
• They are arranged around disease sites: breast, head and neck, GI, GYN oncology, and GU.
• It's a team of providers that provide... radiation oncology, medical oncology, surgical oncology, and
• We're providing medical oncology.
• We are building a space for state-of-the-art radiation oncology with image-guided radiation oncology.

Transcript Highlights:

• It's vital services, the use for oncology programs.
• They said oncology.
• We're talking about very sophisticated oncology care therapies and others.
• > drug has a list price new new oncology drug has a list price new new oncology drug has<01:16
• and oncology or otherwise that those and oncology or otherwise that those really<01:39:55.760> don't

Keywords: 00:00:00 Call to Order/Roll Call 00:01:19 Discussion of 25RS HB 785 00:30:25 Roll Call Vote on 25RS HB 785 00:32:15 Discussion of 25RS HB 61 00:36:42 Roll Call Vote on 25RS HB 61 00:38:07 Discussion of 25RS HB 788 00:51:01 Discussion of 25RS SB 14 01:11:09 Discussion of 25RS HB 685 01:44:57 Adjournment, 958, all

Summary: The House Standing Committee on Health Services met with a quorum and took up House Bill 785, as amended by a committee substitute that combined language from HB 785 and HB 787. The bill was described as addressing Medicaid managed care organization (MCO) audits, provider contract notice and amendment procedures, mental health parity compliance, and related transparency requirements. Supporters said the measure would tighten notice to providers, limit repeated contract amendments and rate reductions, require more standardized audit procedures, and add reporting on Medicaid claims, appeals, and grievances. It also includes a provision requiring coverage of at least two evaluation-and-management billable services per physician per recipient per date of service, and a section addressing narcotic/opioid treatment program licensing and reimbursement language. Testimony in support came from Representative Kim Moore, John Inman of BrightView Health, Michelle Sandborne of the Children’s Alliance, and Kelly Cormic of RYSE. They argued that MCOs often use audits and recoupments in ways that are burdensome, opaque, and financially damaging to providers, especially smaller and rural ones. They cited examples of multiple audit requests in short timeframes, large record requests with short deadlines, delayed or absent feedback, and recoupments taken before appeals are resolved. They also said parity laws are not being consistently enforced and that the bill would give the Department of Insurance authority to suspend or revoke an MCO certificate of authority for willful or repeated parity violations. Committee members generally expressed support for provider protections and transparency, while asking for clarification on the narcotic treatment and E/M billing provisions. Tom Stevens of the Kentucky Association of Health Plans testified in opposition, saying the bill is complex to implement and should be handled through the broader Medicaid oversight work of House Bill 9, the MOAB. He said the issues raised were better suited for that bipartisan stakeholder process and noted the committee substitute had not yet been fully reviewed by his group. After discussion, the committee adopted the committee substitute and then moved to a vote on the bill; the roll call began, with several members recorded as voting yes, but the transcript cuts off before the final vote result is shown.

Transcript Highlights:

• So it's going to be radiation oncology, not interventional radiology. Okay.
• So it just further clarifies direct versus general supervision for radiation oncology.
• Even if radiation oncology and cancer care are there, many of the other specialists that they need, like
• Just recently, we heard that two weeks ago, the medical oncology practice in Southwest Oncology in Bullhead
• When I left Globe as a radiation oncologist, they weren't able to find radiation oncology coverage for

Bills: HB2049, HB2178, HB2179, HB2307, HB2322

Keywords: radiation therapy, particle accelerator, critical access hospitals, patient care, rural healthcare, HB2178, Arizona, state agencies, chief medical officer, medical license, physician license, osteopathic license, licensure requirement, Title 41, Title 32, Arizona Revised Statutes, A.R.S. 41-5902, public health administration, agency leadership, state government personnel

Summary: The Committee on Health and Human Services heard several bills and held HB 2307. HB 2049 would allow particle accelerator treatment for human diseases under general supervision in certain rural counties and critical access hospitals, with documentation, observation, and physician availability requirements. Supporters from the Arizona Hospital and Health Care Association and rural radiation oncologists said it would improve access to cancer care in underserved areas while maintaining safety. The committee also heard HB 2178, requiring state agency chief medical officers to hold an active medical license, and HB 2179, which separates air ambulance definitions and regulations from ground ambulances to clarify statute and align oversight with current practice; both were described as cleanup/common-sense measures and supported by the air medical industry. The committee also heard HB 2322, which would require audio or video recording of DCS interviews with children subject to investigations, with limited exceptions for equipment failure or lack of access. Testimony in support came from a human trafficking survivor, a health care worker and counselor, and a foster parent/child welfare advocate, who argued recordings would improve accuracy, accountability, and child protection, and help preserve a child’s exact words. No opposition was presented. The bill includes a conditional enactment tied to future federal grant legislation and directs DCS to apply for grants if available. After discussion, the committee voted unanimously to give HB 2049, HB 2178, HB 2179, and HB 2322 due pass recommendations, each by a 7-0 vote. The committee then announced HB 2307 would be held and adjourned.

Transcript Highlights:

• savings is used to provide oncology savings is used to provide oncology Services<00:08:04.319>
• in our oncology and fusion Services<00:20:08.679> I<00:20:08.799> mentioned<00:20:09.200
• <00:20:43.159> patients services not only to oncology patients services not only to oncology
• One of the most significant ways that these savings is used is to fund specialty care such as oncology
• Without these savings, the availability of oncology and other critical services would be in jeopardy,

Keywords: 00:00 Introductions 02:46 Roll Call 03:35 Discussion on SB 14 46:13 Vote on SB 14 48:07 Discussion on SB 17 50:38 Vote on SB 17, 958, all

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• dealing with um oncology or cancer care dealing with um oncology or cancer care in<00:08:11.680> the
• subject matter of that doctor unit was, if it was the birthing center or cancer care, you know, oncology
• subject matter of that doctor unit was, if it was the birthing center or cancer care, you know, oncology
• Karan, and I've heard Senator Rest from the other caucus talk about supporting HCMC. um you know oncology
• , radiology, um you know oncology, radiology, whatever<00:12:33.839> it<00:12:34.079> is.

Keywords: 918, senate, all

Summary: The program focused on two major Senate efforts: emergency support for Hennepin County Medical Center (HCMC) and modernization of the state’s human services software systems. On HCMC, Senator Rich Draheim said the hospital is a critical level-one trauma center and a key part of Minnesota’s safety net, warning that its closure would overwhelm the rest of the system. He argued the state should prioritize stabilizing HCMC and other hospitals rather than expanding programs that he считает are not adequately fixed, and he opposed raising taxes such as Hennepin County’s sales tax to fund the hospital, saying property-tax and cost-of-living pressures are already too high. The Senate’s Health and Human Services Supplemental Budget Bill includes a one-time $150 million appropriation to stabilize HCMC, with accountability and reporting requirements. The segment also noted DFL Senator Ann Rest’s bipartisan Senate File 4986, which would direct Hennepin County sales tax revenues to HCMC after certain county obligations are met. Draheim and others emphasized that HCMC’s finances are strained by uncompensated care and low reimbursement rates, and that rural and metro hospitals alike are under pressure. The second half of the program highlighted Senate File 4719, sponsored by Senator Melissa Wicklund, to create a Human Services Systems Steering Committee. Wicklund said outdated, siloed Department of Human Services systems slow access to SNAP, medical assistance, and other basic-needs programs, create errors and inefficiencies, and make fraud harder to detect. She said the committee would bring counties, state agencies, and IT officials together to prioritize modernization. She also said the upgrades would be expensive, citing a child welfare system replacement estimated at nearly $80 million, but noted federal matching funds are available and that failing to modernize could lead to penalties. Wicklund also discussed a longer-term bill, Senate File 5020, to create an IT funding account and planning process for future system upgrades.

Transcript Highlights:

• funding the CORE program, the Clinical Oncology Rural Experience.
• funding the CORE program, the Clinical Oncology Rural Experience.
• meaningful investment in rural oncology meaningful investment in rural oncology workforce<00:39:
• by funding the CORE program, the Clinical Oncology Rural Experience.
• > fellowship With only two oncology fellowship With only two oncology fellowship programs<00:40:23.080

Bills: HF3843, HF3597, HF4003, HF3167, HF4193

Keywords: workforce development, appropriations, nonprofit organizations, employment services, state funding, paid leave, S corporations, employment law, exemptions, Minnesota Statutes, cancer, healthcare, appropriation, Rural Cancer Institute, Minnesota clinicians, pilot program, nursing, education, University of Minnesota, equity

Transcript Highlights:

• Chief Scientific Officer for the Moffitt Cancer Center; Javier Milian, Associate Vice President of Oncology
• We've already administered more than two. and has medical oncology oversight.
• We are partnering with Nimors, where it's a pediatric oncology practice, to really We are partnering
• with Nemours, where it's a pediatric oncology practice, to really bring cancer care beyond walls closer
• So in my role, I am really 100% focused on oncology, so it may not be the best person to answer that.

Summary: The Health Care Budget Subcommittee held a panel discussion on Florida’s cancer research and funding programs, including the Casey DeSantis Cancer Research Program, the Florida Cancer Innovation Fund, the James and Esther King Biomedical Research Program, the Bankhead-Coley Research Program, and Live Like Bella. Dr. Ladapo and leaders from Moffitt, Sylvester/University of Miami, UF Health, and Mayo Clinic described how state funding has helped Florida’s four NCI-designated cancer centers expand research, recruit faculty, increase clinical trials, and build collaborations. They emphasized that the programs are intended to improve cancer care statewide, support innovation, and encourage more institutions to pursue NCI designation. The Governor’s budget recommendation was noted as including additional funding, and members asked about the cost and requirements of becoming NCI-designated and eventually comprehensive. Panelists said NCI designation requires major infrastructure, compliance, research, and training investments, with de novo development estimated at about $1 billion. They described Florida’s collaborative model as unusual nationally, with annual symposia, shared pilot funding, and joint projects across the four centers. Members also asked about rural access, home-based care, and recruitment/retention. Mayo described its “Cancer Care Beyond Walls” home-treatment model and said it could expand to rural counties within months; Moffitt and UF discussed mobile screening, satellite sites, and affiliations with local hospitals and practices. Several members raised concerns about workforce shortages, licensure delays, and the need to reach underserved areas. The discussion also covered outcomes, data reporting, and the broader economic impact of the cancer centers. Panelists cited growth in jobs, federal research funding, and clinical trial enrollment, and highlighted advances in immunotherapy, CAR-T, TIL therapy, carbon ion therapy, AI-driven screening, and the firefighter cancer initiative. They said the Florida Cancer Data System is being expanded to track recurrence and quality-of-life measures. Members also asked about philanthropy, medical tourism, and federal funding risks, including possible indirect cost reductions that could affect research budgets. The meeting ended with general support for continued investment, while some members noted an ongoing policy debate over whether future cancer research dollars should be concentrated in the four NCI centers or spread more broadly across the state.

Transcript Highlights:

• And then finally, we just note that the tying to the 2018 American Society of Clinical Oncology guidelines
• We have written testimony and support from the Society of Clinical Oncology as well as the Fertility
• 10:24.480> Society<00:10:24.880> of<00:10:25.120> Clinical<00:10:25.600> Oncology
• the Society of Clinical Oncology the Society of Clinical Oncology as<00:10:27.600> well<00
• Secondly, to remove reference to the 2018 guidelines of the American Society of Clinical Oncology and

Bills: SB2421, SB2690, SB3103, SB3137, SB3164, SB3206, SB2933, SB3133, SB3315

Keywords: cannabis, marijuana, Hawaii Cannabis Law, legalization, decriminalization, adult use, hemp, taxation, social equity, public health, primary care, health insurance, health carrier, insurance commissioner, Med-QUEST, Medicaid managed care, provider reimbursement, downcoding, prior authorization, utilization review

Summary: The committee heard testimony on several health-related bills. HB 1864, which would require health insurance coverage for standard fertility preservation services for people undergoing medically necessary treatment, drew broad support from SHIPA, the Department of Health, HMSA, the Hawaii Association of Health Plans, and others. Testifiers emphasized that fertility preservation is routine coverage on the mainland and important for patients facing infertility from cancer or other treatment; one patient described incurring more than $20,000 in costs. The Insurance Division flagged possible Affordable Care Act issues, a potential conflict in the bill’s language about using patient history to determine limits, and a mismatch with state medical-necessity standards. Committee discussion also focused on whether the bill should apply to all women of childbearing age rather than a narrower age-based category. HB 2305 would require nutrition and metabolic education as part of physicians’ continuing medical education. The Hawaii Medical Board opposed the measure, arguing that CME should remain flexible and tailored to each physician’s specialty and warning that topic-specific mandates can expand over time. The Office of the Governor supported the bill, saying it would help the state’s rural health transformation application and could improve federal funding prospects, though the exact impact was unclear. Members questioned whether nutrition is already covered in medical training and whether the requirement should be limited to primary care physicians; the board said Hawaii currently has no topic-specific CME mandates and that physicians can already choose relevant courses. The committee also heard strong support for HB 1597, which would establish an Alzheimer’s disease research center at the University of Hawaii. Supporters from the university, the Alzheimer’s Association, AARP, and others said the center could attract federal research dollars, expand clinical trials, and help address the state’s high Alzheimer’s-related health costs. HB 2159, which appropriates funds for health care workforce development, also received broad support from the University of Hawaii, health systems, and advocacy groups, with no opposition noted. Finally, HB 2121, which would prohibit the sale and distribution of disposable electronic smoking devices, drew support from the Department of Health, youth advocates, and public health groups citing youth addiction, environmental waste, and fire hazards; the department said a separate bill, HB 1573, would be more comprehensive and better defined for enforcement and penalties. The committee ended with HB 1913, creating a veteran services mental health coordinator position at Tripler Army Medical Center, which was supported by veteran services officials and others who said veterans need better navigation and coordination for behavioral health care.

Transcript Highlights:

• the initiative is to advance genetic and epigenetic research on inherited eye diseases and ocular oncology
• Department of Health with the Collaborative to provide funding again for the targeted area of pediatric oncology
• During the first five years under the pediatric oncology focus, And under the pediatric oncology focus
• purpose of the initiative is to advance genetic and epigenetic research on inherited eye disease and oncology
• Sometimes they're related, sometimes they're co-occurring. ...disease that's inherited, but oncology.

Summary: The committee took up a large health policy agenda. SB 1568 on electronic prescribing was explained as a federal conformity measure, but members raised concerns about preserving patients’ ability to obtain paper prescriptions and about exemptions for emergency, hospice, and other situations. Emergency physicians testified in support of e-prescribing but asked for flexibility, and the bill was reported favorably despite Senator Harrell’s opposition. SB 1606 on patient access to records sought to standardize record-production timelines and require electronic delivery when available; after an amendment correcting a drafting error, the bill drew concerns about HIPAA, behavioral health confidentiality, and the distinction between personal and legal representatives, and it was reported unfavorably as a committee substitute. The committee then approved SB 1346 on fentanyl testing, with a technical amendment, to require hospitals and campus emergency departments to test for fentanyl in urine testing for suspected overdose or poisoning. SB 1224 on administration of controlled substances by paramedics was amended to clarify language and reported favorably. SB 656 on health care billing and collection activities was substantially revised by strike-all amendment to allow sale of medical debt to third parties under new limits, including no interest or fees and return of debt if charity care applies; it was reported favorably as a committee substitute. SB 68 expanded health facilities authority financing to include not-for-profit LLCs and parent companies, and SB 524 added Duchenne muscular dystrophy to the newborn screening panel; both were reported favorably. Later, the committee approved SB 1842 on out-of-network referrals after multiple amendments, requiring providers to verify network participation at the point of service and notify patients in writing, though several members and physicians warned it could burden providers and increase workload. The committee also advanced proposed committee bill SB 7028, which revises the Casey DeSantis Cancer Research Program, adds oversight and reporting requirements, creates a pediatric cancer research incubator, and establishes the Bascom-Palmer VisionGen initiative; cancer center representatives testified in strong support, and the bill was reported favorably as a committee bill. SB 172 on specialty titles and designations was amended to clarify enforcement and was reported favorably after supporters said it would prevent misleading use of specialist titles, while opponents argued it could confuse practitioners’ titles. Finally, SB 1690 on surrendered infants was reported favorably after supporters said it would codify and expand safe-haven baby box procedures and opponents raised safety concerns about the devices. The committee also noted SB 1606 remained pending for reconsideration next week before adjourning.

Transcript Highlights:

• so we have somewhere to go if someone has a heart attack or um I've had some bills dealing with oncology
• > with<00:07:41.400> um had some bills dealing with um had some bills dealing with um oncology
• :43.240> care<00:07:43.960> in<00:07:44.120> the<00:07:44.200> rural oncology
• or cancer care in the rural oncology or cancer care in the rural areas. areas. areas.
• closing whatever subject matter of that doctor unit was, if it was the birthing center or cancer care, oncology

Keywords: 1187, senate, all

Transcript Highlights:

• Jamie Mercado, who's a registered nurse in pediatric oncology at Sutter Health, and Kerry Stewart, also
• an oncology nurse at Sutter Health as well.
• Jamie Mercado, who's a registered nurse in pediatric oncology at Sutter Health, and Kerry Stewart, also
• an oncology nurse at Sutter Health as well.

Summary: The Assembly met after a quorum call and brief procedural business, including approval of the prior day’s journal, suspension of certain rules for guest introductions, and moving AB 568 to the inactive file. The chamber then recognized several visiting groups, including a fourth-grade class from Marigold Elementary School, representatives of the Pasadena Tournament of Roses and its Royal Court, and students from the University of California Students Association on lobby day. The main floor actions centered on two resolutions. ACR 147 by Assembly Member Lackey designated March 9, 2026 as California Special Olympics Day. Members from both parties spoke in strong support, sharing personal connections to Special Olympics and praising its impact on athletes, families, and volunteers. The resolution received 70 co-authors and was adopted by voice vote. H.R. 89 by Assembly Member Patterson declared March as Colorectal Cancer Awareness Month. Speakers emphasized rising colorectal cancer rates among younger adults, the importance of screening, and new testing options including blood tests. The resolution also received 70 co-authors and was adopted by voice vote. After the resolutions, Assembly Member Rodriguez offered an adjournment in memory of Bob Yuloa of Chino, a Navy veteran and longtime community servant. The Assembly then announced upcoming committee and floor session dates and adjourned until Thursday, March 12 at 9 a.m.

Transcript Highlights:

• generation of trainees to rural oncology generation of trainees to rural oncology practice<01:38
• So, we're hoping to use this model with the oncology lens to have our same pilot program bring people
• <01:42:03.679> practice, exposed to a rural oncology practice, exposed to a rural oncology
• She said that in Staples, where she is located, they see oncology practices closing all around them.
• oncology workers will you train each year?

Keywords: 1187, senate, all

Transcript Highlights:

• an important component of comprehensive cancer care, supported by strong clinical data and major oncology
• The American Society of Clinical Oncology endorses it and has updated coding to facilitate access.
• My name is Jacqueline Olson, and I am a registered nurse with a background in oncology.
• My name is Jacqueline Olson, and I am a registered nurse with a background in oncology.
• Oncology patient navigation extends across the full cancer continuum, beginning with screening and early

Keywords: 995, all

Summary: The committee heard testimony on a wide range of health insurance and public health bills, with most speakers focused on expanding coverage for specific treatments and services. Bills discussed included H. 1187/S. 792 on rehabilitation counselors, H. 1173/S. 692 on patient navigation, S. 2600 on scalp cooling for chemotherapy patients, S. 2599 on medically necessary treatment for port wine birthmarks, H. 1164 on licensed educational psychologists for child and adolescent mental health services, S. 754/H. 1254 on autism diagnosis and treatment by nurse practitioners and psychiatric nurse mental health clinical specialists, S. 714/H. 1137 on infectious disease response and coverage, and S. 791 on making nature a prescriptive therapeutic intervention. Speakers generally argued these bills would improve access, reduce out-of-pocket costs, and address gaps in current insurance reimbursement rules. Testimony in support emphasized personal stories and clinical evidence. Cancer patients and providers described the benefits of patient navigation and scalp cooling for dignity and quality of life during treatment. Boston Children’s Hospital staff and families said port wine birthmark treatment is medically necessary, can prevent complications, and should not be denied as cosmetic. Rehabilitation counselors and school psychologists argued their services are effective, cost-saving, and underused because they cannot bill insurance. Autism advocates said current insurance statutes are outdated because nurse practitioners and psychiatric nurse mental health clinical specialists already provide evaluations and should be recognized for reimbursement to avoid delays in early intervention. Public health and GLAD Law testimony supported stronger infectious disease coverage to remove barriers to testing, treatment, and PrEP access. The hearing also included extensive testimony on H. 1172, a bill requiring insurance coverage for detransition-related care. Supporters said it would ensure coverage for medically necessary care for people who regret or reverse gender transition, while opponents argued it would legitimize anti-trans narratives or, conversely, that detransition care is needed because transition procedures can cause harm. The committee also heard strong support for S. 791 from advocates who described nature access as a health intervention that could help with trauma, anxiety, substance use recovery, and environmental justice, with claims that insurance coverage and reduced park fees would improve access. No votes were taken during the transcript, and the chair repeatedly thanked speakers and moved through the long list of public testimony.

Transcript Highlights:

• And then I just want to read a small paragraph from the Mass Society of Clinical Oncology that has been
• This is a letter from the Mass Society of Clinical Oncology that has been with us for the past several
• The Mass Society of Clinical Oncology has been working closely with us on this current bill, 1258.
• I have worked for the center for four years, and I have a 30-plus-year history as an oncology nurse.
• Oncology is very well funded, researched, and thus a wide variety of treatment options are available.

Keywords: 995, all

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.